Clinical Trial Update: Study Evaluating Desvenlafaxine Succinate Sustained Release In Adults With Major Depressive Disorder [Phase 3]

View source ↗

Summary

Phase 3 study results for desvenlafaxine succinate sustained-release in adults with major depressive disorder were posted, updating the clinical trial status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Desvenlafaxine succinate sustained-release (Desvenlafaxine)

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Major Depressive Disorder | Phase 3 | Status: COMPLETED | Results posted: 2011-05-06